insulin

The US Food and Drug Administration (FDA) has granted approval for Medtronic‘s MiniMed Connect, which provides a mobile connection to critical information for diabetes management.

MiniMed Connect is claimed to be the first product to allow diabetic patients to conveniently view their insulin pump and continuous glucose monitor (CGM) data on a smartphone.

Go deeper with GlobalData

Data Insights

The gold standard of business intelligence.

Find out more

Related Company Profiles

View all

The device provides healthcare teams with convenient access to comprehensive patient data so they can adjust their patients’ care plans.

Medtronic Diabetes Services and Solutions vice-president Annette Brüls said: "With MiniMed Connect, the entire care team can have access to critical diabetes data to inform the decisions that help people have better outcomes.

"MiniMed Connect is claimed to be the first product to allow diabetic patients to conveniently view their insulin pump and continuous glucose monitor (CGM) data on a smartphone."

"The Connect platform represents how we will use leadership technologies, data and informatics to enable better therapy decision making and care for people with diabetes."

Comprising a small device that fits on a keychain or in a pocket, a smartphone app for the patient and a web display on desktop or mobile devices for care partners, MiniMed Connect transfers pump and sensor glucose data from the patient’s insulin pump to the app and web display.

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

The web display shows real-time sensor glucose and insulin information on the phone or any internet-enabled device anytime and anywhere, and is said to be available with iOS, Android or any other internet-enabled devices.

The smartphone app will initially be available with iOS devices.

Medtronic is working with Samsung to also develop an app for Android and optimise experiences on Samsung mobile devices.

Image: MiniMed Connect is designed to provide a mobile connection to critical information for managing diabetes. Photo: courtesy of Ambro / 2015 FreeDigitalPhotos.net.